Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469)

Journal of Medicinal Chemistry

Volumn 44, Issue 11, 2001, Pages 1758-1776

  Hazeldine, S T ^a   Polin, L ^a   Kushner, J ^a   Paluch, J ^a   White, K ^a   Edelstein, M ^a   Palomino, E ^b   Corbett, T H ^a   Horwitz, J P ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Walker Cancer Research Institute   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [(7 CHLORO 2 QUINOXALINYL)OXY]PHENOXY]PROPIONIC ACID; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; XK 469;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NONHUMAN; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; QUINOXALINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035942520     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0005149     Document Type: Article

References (30)

1. Preclinical antitumor activity of XK-469
2. Preclinical antitumor efficacy of analogues of XK469: Sodium 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionate
3. Preclinical antitumor activity of XK469 (NSC656889)
4. Tumor models and the discovery and secondary evaluation of solid tumor active agents
5. XK469. A selective topoisomerase II-β poison
6. Biochemistry of DNA topoisomerases and their poisons
7. Substituted sulfaquinoxalines. III. Extension of the glyoxalate synthesis of 2-aminoquinoxaline
8. Ortho-nitroaniline derivatives. Part 9. Benzimidazole N-oxides unsubstituted at N-1 and C-2
9. Products of rearrangement of m-chloroN-nitro-N-methylaniline
10. The synthesis of some quinoxaline derivatives
11. 2-Hydroxy- and 2-amino-derivatives of 6- and 7-methylquinoxaline
12. Quinoxalines and related compounds. Part V. Some experiments with 1,2-dihydro-2-oxoquinoxalines
13. Cinnolines and other heterocyclic types in relation to the chemotherapy of trypanosomiasis. Part XI. Some reactions of simple quinoxaline derivatives
14. Furazan oxides. III. An unusual type of aromatic substitution reaction
15. Furazan oxides. IV. Extension of the scope of haloalkoxy substitution reaction
16. Ziaudin. Quinoxaline derivatives. III. Cyclization of α-cyano-ortho-nitroacetanilides to quinoxaline N-oxides
17. Studien über verkettungen. XXII. Ortho- und para-amidophenol
18. Covalent modification of cyclooxygenase-2 (COX2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators
19. A facile preparation of aliphatic hydroxamic acid from N,N,O-tris(trimethylsilyl)hydroxylamine and acid chloride
20. Boron trihalide-methyl sulfide complexes as convenient reagents for dealkylation of aryl ethers
21. Discovery of solid tumor active agents using a soft-agar-colony-formation disk-diffusion-assay
22. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice
23. Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice
24. Adaptation of mammary tumors of mice to a soft agar assay for use in drug discovery
25. Discovery of Cryptophycin-1 and BCN-183577: Examples of strategies and problems in the detection of antitumor activity in mice
26. In Vivo methods for screening and preclinical testing; Use of rodent solid tumors for drug discovery